Thomas Stephen Basil

Track

Insider profile

Thomas Stephen Basil's trades of Climb Bio Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Climb Bio Inc (CLYM)
Transaction date
Planned sale
Price
163.02
Quantity 1,846 +33.4%
Value US$2,664,497
US Climb Bio Inc (CLYM)
Transaction date
Proposed sale
Price
32.51
Quantity 68,843
Value US$1,431,084
US Climb Bio Inc (CLYM)
Transaction date
Planned sale
Price
406.61
Quantity 46,560 -27.8%
Value US$3,346,892
US Climb Bio Inc (CLYM)
Transaction date
Planned sale
Price
7.00
Quantity 33,687 -16.5%
Value US$235,964
US Climb Bio Inc (CLYM)
Transaction date
Proposed sale
Price
6.36
Quantity 50,000
Value US$318,000
US Climb Bio Inc (CLYM)
Transaction date
Planned sale
Price
5.81
Quantity 10,000 -4.7%
Value US$58,141
US Climb Bio Inc (CLYM)
Transaction date
Planned sale
Price
5.23
Quantity 90,000 -29.5%
Value US$470,988
US Climb Bio Inc (CLYM)
Transaction date
Proposed sale
Price
5.56
Quantity 100,000
Value US$556,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-17 2026-09-15
US Climb Bio Inc (CLYM)
PlS Planned sale
1,846 +33.4%
163.02
US$2,664,497 		1,846 +33.4% 163.02 US$2,664,497
2026-09-15 2026-09-15
US Climb Bio Inc (CLYM)
PrS Proposed sale
68,843
32.51
US$1,431,084 		68,843 32.51 US$1,431,084
2026-02-27 2026-02-26
US Climb Bio Inc (CLYM)
PlS Planned sale
46,560 -27.8%
406.61
US$3,346,892 		46,560 -27.8% 406.61 US$3,346,892
2026-02-27 2026-02-25
US Climb Bio Inc (CLYM)
PlS Planned sale
33,687 -16.5%
7.00
US$235,964 		33,687 -16.5% 7.00 US$235,964
2026-02-25 2026-02-25
US Climb Bio Inc (CLYM)
PrS Proposed sale
50,000
6.36
US$318,000 		50,000 6.36 US$318,000
2026-02-17 2026-02-13
US Climb Bio Inc (CLYM)
PlS Planned sale
10,000 -4.7%
5.81
US$58,141 		10,000 -4.7% 5.81 US$58,141
2026-02-17 2026-02-12
US Climb Bio Inc (CLYM)
PlS Planned sale
90,000 -29.5%
5.23
US$470,988 		90,000 -29.5% 5.23 US$470,988
2026-02-12 2026-02-12
US Climb Bio Inc (CLYM)
PrS Proposed sale
100,000
5.56
US$556,000 		100,000 5.56 US$556,000